Literature DB >> 33416938

The role of the thymus in allogeneic bone marrow transplantation and the recovery of the peripheral T-cell compartment.

Enrico Velardi1, Emmanuel Clave2, Franco Locatelli3,4, Antoine Toubert2,5, Lucas C M Arruda6, Francesca Benini4.   

Abstract

As the thymus represents the primary site of T-cell development, optimal thymic function is of paramount importance for the successful reconstitution of the adaptive immunity after allogeneic hematopoietic stem cell transplantation. Thymus involutes as part of the aging process and several factors, including previous chemotherapy treatments, conditioning regimen used in preparation to the allograft, occurrence of graft-versus-host disease, and steroid therapy that impair the integrity of the thymus, thus affecting its role in supporting T-cell neogenesis. Although the pathways governing its regeneration are still poorly understood, the thymus has a remarkable capacity to recover its function after damage. Measurement of both recent thymic emigrants and T-cell receptor excision circles is valuable tools to assess thymic output and gain insights on its function. In this review, we will extensively discuss available data on factors regulating thymic function after allogeneic hematopoietic stem cell transplantation, as well as the strategies and therapeutic approaches under investigation to promote thymic reconstitution and accelerate immune recovery in transplanted patients, including the use of cytokines, sex-steroid ablation, precursor T-cells, and thymus bioengineering. Although none of them is routinely used in the clinic, these approaches have the potential to enhance thymic function and immune recovery, not only in patients given an allograft but also in other conditions characterized by immune deficiencies related to a defective function of the thymus.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Cytoreductive therapies; Immune reconstitution; T-cells; Thymus

Year:  2021        PMID: 33416938     DOI: 10.1007/s00281-020-00828-7

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  155 in total

Review 1.  NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia.

Authors:  Franco Locatelli; Daniela Pende; Michela Falco; Mariella Della Chiesa; Alessandro Moretta; Lorenzo Moretta
Journal:  Trends Immunol       Date:  2018-05-21       Impact factor: 16.687

2.  Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.

Authors:  Christina Peters; Martin Schrappe; Arend von Stackelberg; André Schrauder; Peter Bader; Wolfram Ebell; Peter Lang; Karl-Walter Sykora; Johanna Schrum; Bernhard Kremens; Karoline Ehlert; Michael H Albert; Roland Meisel; Susanne Matthes-Martin; Tayfun Gungor; Wolfgang Holter; Brigitte Strahm; Bernd Gruhn; Ansgar Schulz; Wilhelm Woessmann; Ulrike Poetschger; Martin Zimmermann; Thomas Klingebiel
Journal:  J Clin Oncol       Date:  2015-03-09       Impact factor: 44.544

Review 3.  Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies.

Authors:  Christian Chabannon; Jurgen Kuball; Attilio Bondanza; Francesco Dazzi; Paolo Pedrazzoli; Antoine Toubert; Annalisa Ruggeri; Katharina Fleischhauer; Chiara Bonini
Journal:  Sci Transl Med       Date:  2018-04-11       Impact factor: 17.956

4.  Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.

Authors:  Franco Locatelli; Pietro Merli; Daria Pagliara; Giuseppina Li Pira; Michela Falco; Daniela Pende; Roberto Rondelli; Barbarella Lucarelli; Letizia Pomponia Brescia; Riccardo Masetti; Giuseppe Maria Milano; Valentina Bertaina; Mattia Algeri; Rita Maria Pinto; Luisa Strocchio; Raffaella Meazza; Lavinia Grapulin; Rupert Handgretinger; Alessandro Moretta; Alice Bertaina; Lorenzo Moretta
Journal:  Blood       Date:  2017-06-06       Impact factor: 22.113

5.  Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

Authors:  V Rocha; J Cornish; E L Sievers; A Filipovich; F Locatelli; C Peters; M Remberger; G Michel; W Arcese; S Dallorso; K Tiedemann; A Busca; K W Chan; S Kato; J Ortega; M Vowels; A Zander; G Souillet; A Oakill; A Woolfrey; A L Pay; A Green; F Garnier; I Ionescu; P Wernet; G Sirchia; P Rubinstein; S Chevret; E Gluckman
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 6.  Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation.

Authors:  Antonella Mancusi; Loredana Ruggeri; Andrea Velardi
Journal:  Blood       Date:  2016-10-03       Impact factor: 22.113

Review 7.  Umbilical cord blood transplantation: the first 25 years and beyond.

Authors:  Karen K Ballen; Eliane Gluckman; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

8.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

9.  Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

Authors:  F Locatelli; M Zecca; C Messina; R Rondelli; E Lanino; N Sacchi; C Uderzo; F Fagioli; V Conter; F Bonetti; C Favre; F Porta; G Giorgiani; A Pession
Journal:  Leukemia       Date:  2002-11       Impact factor: 11.528

Review 10.  Searching for alternative hematopoietic stem cell donors for pediatric patients.

Authors:  V Rocha; F Locatelli
Journal:  Bone Marrow Transplant       Date:  2007-12-17       Impact factor: 5.483

View more
  4 in total

Review 1.  Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.

Authors:  Patricia A Shi; Larry L Luchsinger; John M Greally; Colleen S Delaney
Journal:  Curr Opin Hematol       Date:  2022-08-29       Impact factor: 3.218

Review 2.  The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation.

Authors:  Flavia Peci; Linde Dekker; Anna Pagliaro; Ruben van Boxtel; Stefan Nierkens; Mirjam Belderbos
Journal:  Bone Marrow Transplant       Date:  2022-06-11       Impact factor: 5.174

Review 3.  Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy.

Authors:  Antonella Cardinale; Carmen Dolores De Luca; Franco Locatelli; Enrico Velardi
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

Review 4.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.